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Estimating the probability of 
dengue virus introduction and 
secondary autochthonous cases in 
Europe
Eduardo Massad1,2,3,4, Marcos Amaku  1, Francisco Antonio Bezerra Coutinho1, Claudio José 
Struchiner5, Marcelo Nascimento Burattini1,6, Kamran Khan7, Jing Liu-Helmersson8, Joacim 
Rocklöv8, Moritz U. G. Kraemer9 & Annelies Wilder-Smith8,10,11
Given the speed of air travel, diseases even with a short viremia such as dengue can be easily exported 
to dengue naïve areas within 24 hours. We set out to estimate the risk of dengue virus introductions via 
travelers into Europe and number of secondary autochthonous cases as a result of the introduction. 
We applied mathematical modeling to estimate the number of dengue-viremic air passengers from 16 
dengue-endemic countries to 27 European countries, taking into account the incidence of dengue in 
the exporting countries, travel volume and the probability of being viremic at the time of travel. Our 
models estimate a range from zero to 167 air passengers who are dengue-viremic at the time of travel 
from dengue endemic countries to each of the 27 receiving countries in one year. Germany receives 
the highest number of imported dengue-viremic air passengers followed by France and the United 
Kingdom. Our findings estimate 10 autochthonous secondary asymptomatic and symptomatic dengue 
infections, caused by the expected 124 infected travelers who arrived in Italy in 2012. The risk of onward 
transmission in Europe is reassuringly low, except where Aedes aegypti is present.
Arboviral diseases are on the rise, with dengue viral infections taking the lead1. The distribution of Aedes aegypti 
and Ae. albopictus mosquitoes - the vectors for dengue- is now the widest ever recorded; extensive in all conti-
nents, including North America and Europe, with over three billion people living in Aedes-infested countries or 
areas2. Although Aedes aegypti, remains a vector predominantly of the tropics and subtropics, the global spread of 
Ae. albopictus fuelled by global trade and travel3, and its resistance to colder weather2, put temperate areas such as 
Europe at risk for transmission of dengue and other Aedes transmitted viruses. Figure 1 depicts the distribution 
of Aedes albopictus in Europe. Some model studies predict that climate change will increase dengue epidemic 
potential in temperate regions, potentially flattening the differences between tropical and temperate zones4–6. 
Compared with the tropics, Europe shows pronounced seasonality which affects temperature-dependent prolif-
eration of Aedes mosquitoes. Although vectorial capacity – the mosquito’s capacity to transmit dengue virus to 
humans – is low in Europe according to modeling estimates, vectorial capacity is sufficient during the summer 
months for a dengue outbreak to occur in most of Southern Europe4. Indeed, small autochthonous dengue clus-
ters occurred in Southern France and in Croatia in 20107, and a major dengue outbreak involving more than 
2000 persons occurred in Madeira/Portugal in 20128, underpinning that the threat of dengue to Europe is real. 
The potential for dengue outbreaks to occur in Europe depends on two main factors: (1) the presence of Aedes 
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vectors during the summer season when vectorial capacity is sufficient to sustain transmission and (2) the rate of 
dengue virus importations, that depends on the number of dengue viremic travelers entering Europe. Most of the 
modeling work has been focused on understanding the risk of local transmission and relatively little attention has 
been given to the extent of disease importations. As human movements resulting in global spread of infectious 
diseases including vector-borne diseases are increasing9–18 and the burden of diseases such as dengue increases, 
we can expect an exponential increase in arrivals of viremic passengers which may challenge traditional health 
infrastructures.
Given the speed of air travel today19 and increase of travel to tropical and subtropical countries19, diseases 
with short viremia such as dengue (around 7 days) can be easily exported to a dengue naïve areas within 24 hours, 
where mosquitoes may then be able to feed on viremic blood, and transmit the virus on to other humans. A sen-
tinel surveillance study recently estimated that about 40% of travelers diagnosed with dengue are viremic at the 
time of arrival in Europe20. The first large dengue outbreak in Europe that occurred in Madeira in 2012 as a result 
of importation of the virus via incoming viremic air passengers most likely from Venezuela8 prompted us to study 
the extent of potentially dengue viremic travelers arriving in Europe as a whole in the same year and to estimate 
the probability of secondary transmission in Europe as a result of such importation. In the absence of good 
empiric data on importation of dengue via viremic travelers, mathematical models can provide an additional tool 
to estimate the number of dengue virus introductions21. The extent of dengue virus introduction is a function of 
travel volume and dengue incidence in the ‘exporting’ country22,23. We set out to model the estimated numbers of 
dengue-viremic air passengers from dengue-endemic countries to 27 European countries and the subsequent risk 
of autochthonous transmission as a result of such importation.
Methods
We applied a previously published mathematical model to estimate the risk of importation of infectious diseases 
via travelers21, and expanded it to further to include models on vectorial capacity4,5. To estimate the number 
of dengue viremic air passengers into Europe in one year we took into account air travel volume, the dengue 
monthly incidence in the country of origin, and the probability for the air passenger to be viremic at the time of 
travel.
We consider two types of countries, the ‘exporting’ country (where the infection is endemic) and those 
‘importing’ or ‘receiving’ countries. We investigated the number of imported dengue-viremic travelers into 27 
European countries based on the following variables: (1) the monthly dengue incidence in the exporting coun-
tries; (2) the monthly number of people leaving the airports of exporting countries and traveling to importing 
countries; (3) the expected monthly number of dengue-viremic travelers arriving at the importing countries. 
(4) the accumulated number of secondary cases in humans in the importing countries generated by the infected 
travelers from the exporting countries taking into account the vectorial capacity of Aedes mosquitoes in the 
importing countries over a one year period; and (5) the accumulated per capita risk of dengue infection in the 
population of the importing countries over one year caused by infected travelers arriving in that year. Items 4 and 
5 will be exemplified by the cases of Italy, in which Aedes albopictus is currently present, and Madeira, where Aedes 
aegypti caused an important outbreak in 2012. Aedesalbopictus is a much less competent mosquito for dengue 
Figure 1. European countries in which Aedes albopictus was present in 2012 (From Environmental Risk Mapping: 
Aedes albopictusin Europe. European Centre for Disease Prevention and Control (ECDC Technical Report), 
Environmental risk mapping: Aedes albopictus in Europe, Stockholm: ECDC; 2013, available at: https://www.google.
com.br/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&ved=0ahUKEwjVuMCy1v7UAhVJIJAKHQIxB_
kQFggpMAE&url=http%3A%2F%2Fecdc.europa.eu%2Fen%2Fpublications%2FPublications%2Fclimate-change-
environmental-risk-mapping-aedes.pdf&usg=AFQjCNEKPAVsU4vqMfGXjL4pHcqy9EXz-A&cad=rja.
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transmission than Aedes aegypti; Tables S2 and S3 in the supplement list the values of the transmission parameters 
that we used for our models on vectorial capacity.
Estimating the incidence of dengue in the exporting countries. The first step was to obtain infor-
mation on dengue cases notified to the World Health Organization (WHO) from their website (www.who.int). 
From the 85 countries that reported 1,597,220 dengue cases to WHO in 2012 we selected 16 countries which were 
responsible for 95% of all the cases. These countries, along with the number and relative contribution to the total 
number of dengue cases are shown in Table S1 (supplementary material). Of these 16 selected countries, 9 are 
from South and Central America, and the rest from Asia. As cases are only reported to WHO on an annual basis, 
we inferred the seasonal distribution per month from those two countries where we had monthly data: Brazil and 
Thailand. We assumed that the 9 South and Central American countries had seasonality similar to that of Brazil. 
The remaining 7 Asian countries were assumed to have the same seasonality as Thailand. The seasonal pattern of 
these two reference countries, Brazil and Thailand, are shown in figures S1 to S4 (supplementary material). We 
assumed that visitors to the exporting countries were subject to the same risk of infection as the local inhabitants.
Estimating the monthly number of people leaving the airports of exporting countries and trav-
eling to importing countries. The second step is to fit a continuous function to the number of actually 
reported dengue cases (incidence) multiplied by 4 to take into account the 4:1 asymptomatic:symptomatic ratio 
for dengue infections24. The continuous function chosen has the form:
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representing the time-dependent dengue infection incidence. In equation (1) c1 is a scale parameter that deter-
mines the maximum incidence, c2 is the time at which the maximum incidence is reached, c3 represents the width 
of the time-dependent incidence function and c4 is a time and location dependent parameter to counter the sea-
sonal differences in dengue incidence between Northern and Southern Hemisphere. Equation (1) reproduces a 
“Gaussian” curve and so c1 and c4 are just scale parameters but c2 crepresents the “mean” (and mode or maximum) 
time and c3 represents the “variance” of the time distribution of cases. All parameters c1,i = 1, …, 4 fitted to func-
tion (1), when used in the dynamical model described below reproduces the observed incidence of dengue for a 
given outbreak in a region preferably small as we will explain later. Parameter c4 is given by:
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where rect (t) is a rectangular function added to equation (1) to take account of the slight increase in the risk at 
the end of the year in the Southern Countries (summer time). The rectangular function is a square pulse of deter-
mined duration and can be written in terms of the Heaviside step function as θ(t + ti) − θ(t − ti). The rect (t) is 
zero for any t > |ti| and is equal to 1 for t < |ti|.
The number of monthly reported dengue cases of all 16exporting countries, was used to estimate the monthly 
prevalence of dengue in each country. Therefore, all the quantities should have a superscript j (j = 1 … 12) denot-
ing the months of the year. We used previously developed and validated models (1) and (2)21,24–26 to the human 
components of the Ross-Macdonald model, in which S t( )H
j , I t( )H
j  and R t( )H
j  represent the susceptible, infected and 
recovered humans in each month of the year, respectively and μH and γH are the humans natural mortality and 
recovery from infection rates, respectively.
The model is described by the following set of equations:
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such that the parameters ci, i = 1, …, 4 of equation (1) reproduce the incidence data (reported cases). This system 
is valid for any specific dengue serotype. As we are working with reporting cases of dengue, we are not concerned 
with the particular serotype circulating.
The first term of the first equation in system of equations (3) (Incidence t( )DENV
j ) models the number of new 
infections per time unit. In terms of the classical notation of vector-borne infections27 it is equal to the product of 
the force-of-infection, λj(t) times the number of susceptible humans, denoted S t( )H
j . As is well known, the 
force-of-infection in vector-borne infections is the product of the biting rate times the probability of transmission 
from infected mosquitoes to the human hosts, times the number of infected mosquitoes divided by the total 
number of humans27.
Remark: λj(t)S t( )H
j  is the dengue incidence:
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The individual probability of being infected at time t, defined as the monthly individual risk of being infected 
and denoted Risk t( )DENV
j , which is given by the prevalence of dengue:
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This risk is obtained as follows. From the second equation of model (3) for the infected humans we obtain:
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which can be integrated by standard methods to obtain:
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Note that the concept of risk expressed in equation (4) means the probability of finding at least one dengue 
case at month j, either among travellers who visited each of the selected countries or among local inhabitants. 
In addition, equation (4) includes the notion that a proportion of the infected individuals can recover from the 
infection or die after they arrive at one of the European countries.
Estimating the number of dengue-viremic air passengers arriving in the importing coun-
tries. We obtained the expected number of passengers arriving in European countries infected with dengue 
in the exporting countries by multiplying equation (4) by the number of air passengers from the 16 selected 
countries with final destinations in any of the 27 European countries. We analysed worldwide full-route flight 
itinerary data, taking into consideration all flight connections between those 16 exporting countries and 27 
receiving European countries, from the International Air Transport Association (IATA) between 1 January and 
31 December 2012.
Estimating the monthly number of secondary dengue infections in humans in the importing 
countries generated by dengue-viremic travelers from the exporting countries based on vecto-
rial capacity in that country. In order to estimate the monthly number of autochthonous mosquitoes and 
humans we used again the Ross-Macdonald in its full version.
Infected (i.e., dengue-viremic) travellers arrive at each month j of the year and are denoted =I t( )H
j  
θ −μ γ− + −I t e t t( ) ( )H
j j t t j( )( )H H
j
. In the model we denote the mosquitoes densities as m t( )j I t
N
( )M
I
H
I
 and the superscript I 
denotes importing countries. The mosquitoes densities SM
I , LM
I  and IM
I , representing the susceptible, latent and 
infected mosquitoes, respectively, were calculated according to the methods described in.4 Total human popula-
tion sizes, NH
I , are obtained from demographic data for each country. The model has the form:
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Note that both the humans’ and mosquitoes’ populations are assumed to be constant and the last terms of the 
susceptible humans and susceptible mosquitoes are included to mimic births as equal to deaths. This is based on 
the assumption that dengue does not have any significant impact in humans nor mosquitoes in terms of mortality.
The values of the pulse-like parameters are given in4. For the sake of clarity, let us exemplify how the param-
eters in model (7) enter the code.Let us take the biting rate, for instance, aj(t). As shown in4, it varies with tem-
perature and hence with time, that is, it varies seasonally. Its value should be written as aj(t) = Aj[θ(t + tj) − θ(t 
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− tj+1)], where Aj is the value of the biting rate obtained from4 for the month j. In other words, the biting rate 
assumes ‘discrete’ values in each month of the year.We did these calculations for Italy only where we used the 
average temperature month-by-month and applied the parameters from Table S2.
The densities I t( )H
I  and I t( )M
I  representing the autochthonous humans and mosquitoes infected by the infected 
travellers, I t( )H
I , were obtained by numerically simulating model (7).
The above calculation is restricted to the autochthonous cases generated exclusively by infected travellers. If 
one is interested in the total number of dengue cases one should substitute the fourth and fifth equations of model 
(7) by:
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Results
Figure 2 shows the countries that present more than 80% of the dengue burden (16 dengue endemic countries). 
Table 1 provides the probability of an air passenger being dengue viremia at the time of travel from the selected 
16 exporting countries with the highest dengue incidence in the world to the 27 European destination countries 
for every month in the year 2012. Table 2 shows the expected number of dengue viremic air passengers from each 
of the 16 exporting countries, stratified by country of disembarkation and by country of arrival. Table 3 depicts 
the number of dengue viremic air passengers arriving in each of the 27 countries by month of arrival, and in total 
over the year of 2012. This table shows a range from zero to 167 dengue-viremic travelers arriving in each of the 
European importing countries. Germany receives the highest number of imported dengue-viremic air passen-
gers (167), followed by France (150) and the United Kingdom (148). Figures 3 and 4 illustrate the countries that 
receive the highest amount of dengue virus importations via incoming air passengers.
Autochthonous transmission as a result of dengue virus importation. The risk of onward trans-
mission via Aedes mosquitoes depends on the presence of such mosquitoes, and Fig. 1 shows the Aedes albopictus 
distribution in Europe. From Fig. 1 it is evident that only Italy has nationwide presence of Aedes albopictus. As the 
air passenger flight information was available only at a country level, we were only able to calculate the probability 
of onward transmission where the presence of Aedes albopictus is countrywide. Hence, we selected Italy to illus-
trate the method to calculate the number of secondary autochthonous cases in one year as a result of dengue virus 
importation via incoming air passengers from dengue endemic countries. Table 3 shows the monthly number of 
dengue viremic air passengers arriving in Italy. Of the total number of 124 infected travellers to Italy in one year, 
51 arrived in the summer months of June, July and August, a seasonal window with the most suitable vectorial 
capacity for Aedes mosquitoes based on previous calculations on the seasonal variation of vectorial capacity in 
different European cities by Liu-Helmersson et al.4. Out model estimated that 10autochthonous (secondary) cases 
would occur as a result of 51 air passengers arriving in Italy at a time of being dengue viremic. These 10 persons 
include 2 (20%) symptomatic dengue cases, assuming a 4:1 ratio of asymptomatic to symptomatic infections.
We also validated our models against the well-documented dengue outbreak in Madeira with 2180 reported 
dengue cases. We estimated the risk of autochthonous transmission for the Madeira Islands where Aedes aegypti 
Figure 2. Selected countries with the highest reported number of dengue cases in 2012 (The values are 
normalized per 1 million passengers. Brazil has the highest absolute numbers but not per million).
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Month
Brazil Bolivia
Prev. Trav. Inf. Prev. Trav. Inf.
Jan 4.55E-07 219536 0 ± 0 9.09E-06 10330 0 ± 0
Feb 1.75E-04 188345 33 ± 5 6.39E-05 8241 1 ± 0
Mar 3.35E-04 201075 67 ± 11 1.23E-04 6931 1 ± 0
Apr 4.40E-04 205969 91 ± 15 1.62E-04 5974 1 ± 0
May 4.00E-04 217757 87 ± 14 1.47E-04 8210 1 ± 0
Jun 2.57E-04 219886 57 ± 9 9.25E-05 5046 0 ± 0
Jul 1.26E-04 242269 31 ± 5 4.83E-05 4931 0 ± 0
Aug 6.18E-05 217028 13 ± 2 2.37E-05 6726 0 ± 0
Sep 4.66E-05 239181 11 ± 2 1.73E-05 6389 0 ± 0
Oct 5.11E-05 202519 10 ± 2 1.88E-05 4578 0 ± 0
Nov 6.11E-05 176584 11 ± 2 2.24E-05 3896 0 ± 0
Dec 7.28E-05 209612 15 ± 2 2.67E-05 4495 0 ± 0
Total 2539761 426 ± 68 75747 5 ± 1
El Salvador Paraguay
Jan 1.56E-05 3193 0 ± 0 1.47E-05 4561 0 ± 0
Feb 4.30E-04 2267 1 ± 0 3.78E-04 3125 1 ± 0
Mar 8.26E-04 2599 2 ± 0 7.27E-04 3358 2 ± 0
Apr 1.09E-03 2236 2 ± 0 9.59E-04 3500 3 ± 0
May 9.91E-04 2300 2 ± 0 8.72E-04 2992 3 ± 0
Jun 6.22E-04 2257 1 ± 0 5.47E-04 2771 2 ± 0
Jul 3.26E-04 2838 1 ± 0 2.87E-04 2941 1 ± 0
Aug 1.60E-04 2965 0 ± 0 1.40E-04 3249 0 ± 0
Sep 1.17E-04 2810 0 ± 0 1.03E-04 2740 0 ± 0
Oct 1.26E-04 1979 0 ± 0 1.11E-04 2517 0 ± 0
Nov 1.51E-04 2178 0 ± 0 1.32E-04 2244 0 ± 0
Dec 1.79E-04 2312 0 ± 0 1.58E-04 2463 0 ± 0
Total 29934 12 ± 2 36461 14 ± 2
Thailand Mexico
Jan 1.47E-06 329531 0 ± 0 8.33E-07 117193 0 ± 0
Feb 8.95E-06 321815 3 ± 0 1.07E-05 96836 1 ± 0
Mar 2.25E-05 343328 8 ± 0 2.69E-05 127676 3 ± 0
Apr 4.64E-05 287581 13 ± 1 5.55E-05 115295 6 ± 0
May 7.90E-05 198580 16 ± 1 9.46E-05 110254 10 ± 1
Jun 1.11E-04 159959 18 ± 1 1.33E-04 107635 14 ± 1
Jul 1.29E-04 204990 26 ± 2 1.54E-04 150928 23 ± 1
Aug 1.23E-04 263979 32 ± 2 1.47E-04 132677 20 ± 1
Sep 9.69E-05 177433 17 ± 1 1.16E-04 118734 14 ± 1
Oct 6.30E-05 190476 12 ± 0 7.55E-05 103697 8 ± 0
Nov 3.38E-05 232273 8 ± 0 4.05E-05 103867 4 ± 0
Dec 1.50E-05 255261 4 ± 0 1.80E-05 110462 2 ± 0
Total 2965206 157 ± 8 1395254 105 ± 5
VietNan India
Jan 1.09E-06 37536 0 ± 0 8.33E-08 267443 0 ± 0
Feb 5.86E-06 45905 0 ± 0 3.17E-07 259617 0 ± 0
Mar 1.47E-05 56547 1 ± 0 8.04E-07 271524 0 ± 0
Apr 3.03E-05 49196 1 ± 0 1.67E-06 241751 0 ± 0
May 5.16E-05 38800 2 ± 0 2.87E-06 236148 1 ± 0
Jun 7.25E-05 32644 2 ± 0 4.05E-06 211554 1 ± 0
Jul 8.40E-05 41518 3 ± 0 4.70E-06 178268 1 ± 0
Aug 8.03E-05 60324 5 ± 0 4.49E-06 208148 1 ± 0
Sep 6.33E-05 37414 2 ± 0 3.53E-06 212047 1 ± 0
Oct 4.12E-05 37866 2 ± 0 2.29E-06 203889 0 ± 0
Nov 2.21E-05 44399 1 ± 0 1.22E-06 222536 0 ± 0
Dec 9.80E-06 42322 0 ± 0 5.36E-07 209710 0 ± 0
Total 524471 19 ± 1 2722635 6 ± 0
Colombia Venezuela
Continued
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Month
Brazil Bolivia
Prev. Trav. Inf. Prev. Trav. Inf.
Jan 2.05E-06 49522 0 ± 0 1.09E-06 37536 0 ± 0
Feb 6.68E-05 36188 2 ± 0 5.86E-06 45905 0 ± 0
Mar 1.28E-04 37645 5 ± 2 1.47E-05 56547 1 ± 0
Apr 1.69E-04 36004 6 ± 2 3.03E-05 49196 1 ± 0
May 1.54E-04 35016 5 ± 2 5.16E-05 38800 2 ± 0
Jun 9.66E-05 43833 4 ± 1 7.25E-05 32644 2 ± 0
Jul 5.05E-05 39760 2 ± 0 8.40E-05 41518 3 ± 0
Aug 2.47E-05 43313 1 ± 0 8.03E-05 60324 5 ± 2
Sep 1.81E-05 46471 1 ± 0 6.33E-05 37414 2 ± 0
Oct 1.96E-05 33870 1 ± 0 4.12E-05 37866 2 ± 0
Nov 2.34E-05 27996 1 ± 0 2.21E-05 44399 1 ± 0
Dec 2.79E-05 35964 1 ± 0 9.80E-06 42322 0 ± 0
Total 465582 29 ± 5 524471 19 ± 3
Nicaragua Peru
Jan 1.82E-05 4319 0 ± 0 3.18E-06 37917 0 ± 0
Feb 3.84E-04 3103 1 ± 0 6.29E-05 32099 2 ± 0
Mar 6.99E-04 5559 4 ± 1 1.21E-04 35671 4 ± 1
Apr 9.06E-04 3354 3 ± 0 1.59E-04 34973 6 ± 2
May 8.40E-04 2138 2 ± 0 1.45E-04 35067 5 ± 2
Jun 5.59E-04 2373 1 ± 0 9.10E-05 32091 3 ± 0
Jul 2.67E-04 3203 1 ± 0 4.76E-05 36909 2 ± 0
Aug 9.15E-05 4725 0 ± 0 2.33E-05 47779 1 ± 0
Sep 2.25E-05 3055 0 ± 0 1.71E-05 42400 1 ± 0
Oct 3.99E-06 2294 0 ± 0 1.85E-05 35951 1 ± 0
Nov 5.10E-07 2437 0 ± 0 2.20E-05 31968 1 ± 0
Dec 4.70E-08 3628 0 ± 0 2.63E-05 31286 1 ± 0
Total 40188 12 ± 2 434111 26 ± 4
Philipines Indonesia
Jan 9.62E-07 55280 0 ± 0 4.00E-07 39665 0 ± 0
Feb 8.37E-06 43699 0 ± 0 2.31E-06 35706 0 ± 0
Mar 2.43E-05 49190 1 ± 0 5.80E-06 48580 0 ± 0
Apr 5.58E-05 55224 3 ± 0 1.20E-05 53312 1 ± 0
May 1.01E-04 50788 5 ± 0 2.04E-05 57147 1 ± 0
Jun 1.46E-04 41218 6 ± 0 2.86E-05 60615 2 ± 0
Jul 1.73E-04 44283 8 ± 0 3.32E-05 58816 2 ± 0
Aug 1.60E-04 55526 9 ± 0 3.17E-05 93998 3 ± 0
Sep 1.20E-04 41590 5 ± 0 2.50E-05 66425 2 ± 0
Oct 7.65E-05 37065 3 ± 0 1.63E-05 62270 1 ± 0
Nov 4.63E-05 38321 2 ± 0 8.73E-06 50952 0 ± 0
Dec 3.24E-05 37204 1 ± 0 3.87E-06 47755 0 ± 0
Total 549388 43 ± 1 675241 12 ± 1
Sri Lanka Cambodia
Jan 4.76E-06 39596 0 ± 0 6.45E-06 6809 0 ± 0
Feb 2.27E-05 43411 1 ± 0 1.81E-05 7247 0 ± 0
Mar 5.39E-05 44986 2 ± 0 5.25E-05 8484 0 ± 0
Apr 1.07E-04 33877 4 ± 0 1.21E-04 6269 1 ± 0
May 1.78E-04 32341 6 ± 0 2.20E-04 5695 1 ± 0
Jun 2.47E-04 20127 5 ± 0 3.16E-04 4332 1 ± 0
Jul 2.83E-04 29428 8 ± 0 3.75E-04 6739 3 ± 0
Aug 2.74E-04 46863 13 ± 0 3.46E-04 8259 3 ± 0
Sep 2.21E-04 39697 9 ± 0 2.60E-04 5710 1 ± 0
Oct 1.46E-04 35634 5 ± 0 1.66E-04 4193 1 ± 0
Nov 7.66E-05 30039 2 ± 0 1.00E-04 9208 1 ± 0
Dec 2.71E-05 27551 1 ± 0 7.01E-05 8508 1 ± 0
Total 229 56 ± 3 13 ± 1
Table 1. Probability of being infected with dengue (Prev. = equation (4)), number of travelers (Trav.), and 
expected number of infected people (Inf.) leaving the airports of the 16 selected countries by month in 2012.
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Brazil Mexico Philippines Thailand Indonesia Viet Nam India Colombia
Albania 0 0 0 0 0 0 0 0
Austria 5 1 1 4 0 0 0 0
Belgium 5 2 1 6 0 0 0 0
Bulgaria 0 0 0 0 0 0 0 0
Czech 3 1 0 1 0 1 0 0
Germany 44 12 5 31 2 5 1 3
Dennmark 5 1 1 8 0 1 0 0
Spain 46 30 2 5 0 0 0 13
Finland 1 0 0 2 0 0 0 0
France 70 17 3 20 2 5 1 3
Greece 3 1 1 1 0 0 0 0
Switzerland 19 3 1 10 1 1 0 1
UK 50 13 13 32 2 3 2 3
Croatia 1 0 0 0 0 0 0 0
Hungary 2 0 0 1 0 0 0 0
Italy 69 13 6 10 1 1 1 3
Malta 0 0 0 0 0 0 0 0
Netherland 14 6 3 9 2 1 1 1
Norway 4 1 2 6 0 1 0 0
Poland 14 2 0 1 0 0 0 0
Portugal 68 1 0 1 0 0 0 0
Romania 1 0 0 1 0 0 0 0
Serbia 0 0 0 0 0 0 0 0
Sweden 4 1 1 8 0 0 0 0
Slovenia 0 0 0 0 0 0 0 0
Slovakia 0 0 0 0 0 0 0 0
Turkey 7 1 0 2 0 0 0 0
Total 426 ± 68 105 ± 5 43 ± 1 157 ± 8 12 ± 1 19 ± 1 6 ± 0 29 ± 5
Venezuela Sri Lanka Bolivia El Salvador Cambodia Paraguay Nicaragua Peru
Albania 0 0 0 0 0 0 0 0
Austria 0 1 0 0 0 0 0 0
Belgium 0 1 0 0 0 0 0 0
Bulgaria 0 0 0 0 0 0 0 0
Czech 1 1 0 0 0 0 0 0
Germany 5 8 0 1 1 6 2 2
Dennmark 1 1 0 0 0 0 0 0
Spain 0 0 3 4 0 3 4 7
Finland 0 0 0 0 0 0 0 0
France 5 5 1 2 8 1 2 5
Greece 0 0 0 0 0 0 0 0
Switzerland 1 4 0 0 0 1 0 1
UK 3 22 0 1 1 1 1 3
Croatia 0 0 0 0 0 0 0 0
Hungary 0 0 0 0 0 0 0 0
Italy 1 9 0 2 0 1 1 4
Malta 0 0 0 0 0 0 0 0
Netherland 1 1 0 0 1 0 1 1
Norway 1 0 0 0 0 0 0 1
Poland 0 0 0 0 0 0 0 0
Portugal 0 0 0 0 0 0 0 0
Romania 0 0 0 0 0 0 0 0
Serbia 0 0 0 0 0 0 0 0
Sweden 0 1 0 0 0 0 0 1
Slovenia 0 0 0 0 0 0 0 0
Slovakia 0 0 0 0 0 0 0 0
Turkey 0 0 0 0 0 0 0 0
Total 19 ± 3 56 ± 3 5 ± 1 12 ± 2 13 ± 1 14 ± 2 12 ± 2 26 ± 4
Table 2. Expected number of dengue viremic air passengers from the 16 dengue endemic countries arriving in 
27 European countries in 2012, by country of disembarkation.
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was responsible for a large dengue outbreak in 2012, as well as the expected number of secondary cases resulting 
from the introduction of imported cases from Venezuela and Brazil. Our models estimated the per capita prob-
ability to be 0.035 and the expected number of secondary cases to be 2205, which is well in agreement with the 
2180 reported cases in the 2012 outbreak.
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
Albania 0 0 0 0 0 0 0 0 0 0 0 0 0 ± 1
Austria 0 1 1 2 2 2 2 2 1 1 1 0 15 ± 2
Belgium 0 1 2 2 2 2 3 3 1 1 1 0 18 ± 2
Bulgaria 0 0 0 0 1 0 0 0 0 0 0 0 1 ± 0
Czech 0 0 1 1 1 1 1 1 1 1 0 0 8 ± 1
Germany 0 9 21 28 27 19 16 16 12 8 6 5 167 ± 18
Denmark 0 1 2 2 3 2 4 3 1 1 1 0 20 ± 2
Spain 0 7 14 19 19 16 14 10 7 5 3 3 120 ± 13
Finland 0 0 1 1 1 1 1 0 0 0 0 0 5 ± 0
France 0 7 17 22 24 19 17 18 9 6 6 5 150 ± 16
Greece 0 0 1 1 1 1 1 1 0 0 0 0 6 ± 0
Switzerland 0 3 5 6 6 5 5 7 2 2 2 1 45 ± 5
UK 0 6 12 19 22 19 19 18 14 9 5 4 148 ± 16
Croatia 0 0 0 0 0 1 0 0 0 0 0 0 1 ± 0
Hungary 0 0 0 0 1 1 0 0 0 0 0 0 2 ± 0
Italy 0 7 15 20 21 15 13 13 8 5 3 3 124 ± 13
Malta 0 0 0 0 0 0 0 0 0 0 0 0 0 ± 0
Netherlands 0 2 4 5 6 5 6 7 3 2 1 1 42 ± 5
Norway 0 1 1 2 2 2 4 3 1 1 0 0 17 ± 2
Poland 0 0 1 1 1 1 1 0 0 0 0 0 5 ± 0
Portugal 0 5 10 16 14 10 5 3 2 2 2 3 71 ± 8
Rumania 0 0 0 1 1 0 0 0 0 0 0 0 2 ± 0
Serbia 0 0 0 0 0 1 0 0 0 0 0 0 1 ± 0
Sweden 0 1 2 2 2 2 3 2 1 1 1 1 18 ± 2
Slovenia 0 0 0 0 0 0 0 0 0 0 0 0 0 ± 0
Slovakia 0 0 0 0 0 0 0 0 0 0 0 0 0 ± 0
Turkey 0 0 0 0 0 0 0 0 0 0 0 0 0 ± 0
Table 3. Expected Number of Passengers Arriving Infected With Dengue at European Countries every month 
in 2012, and in total in the year 2012.
Figure 3. Expected number of dengue infections in air passengers arriving in European countries from the 16 
selected countries in 2012.
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Table 4 summarizes the cumulative per capita risk and expected number of autochthonous cases for Italy 
(Aedes albopictus) and the Madeira Islands (Aedes aegypti). The parameters used for the simulations can be found 
in Table S2 (Aedes albopictus) and S3 (Aedes aegypti) of the supplementary material.
Discussion
Although reported autochthonous cases in Europe in the recent past highlight the threat of dengue to Europe27, 
the extent of such a threat has not been quantified. This is the first attempt to quantify the actual number of den-
gue viremic air passengers from dengue endemic countries into Europe -an important parameter that determines 
the risk calculations of subsequent local dengue virus outbreaks. As not only clinically apparent viremic cases 
transmit dengue viruses28, we also included asymptomatic infections into our calculations at a published ratio of 
4:1. Our estimated number of importations tally with the reported importations of dengue in Europe, although 
the numbers are slightly lower as we are focusing only on air passengers traveling to Europe still in the viremic 
phase (e.g. persons traveling at a time of viremia for the short period within 5 days after onset of symptoms)20,29. 
The majority of dengue cases reported in returning travelers to Europe are not viremic anymore at the time of 
arrival20.
The highest number of dengue virus importations via air travelers were modeled to occur in Germany, France 
and the United Kingdom. Aedes albopictus was recently introduced to Kent, United Kingdom but its distribution 
is very limited and not yet established30. In Germany, many more Aedes albopictus have been reported and estab-
lished populations have been recorded in parts of Southern Germany2,31. However, risk for local transmission is 
limited under current climatic conditions. Both France and Italy receive a significant number of modeled dengue 
infected air passengers and both countries have significant presence of Aedes albopictus- indeed France experi-
enced autochthonous dengue transmission in the year 2010 in Nice in the Southern part of its country7 and Italy 
experienced a chikungunya outbreak in 2007 in the Northern part of Italy32. We were limited to passenger flight 
information at a country level, so we restricted our analysis of the risk of onward transmission of dengue to Italy, 
a country where Aedes albopictus is distributed across the majority of the country.
For Italy, we modeled the probability for an imported case to result in secondary cases by taking into account 
the monthly vectorial capacity where transmission is most suitable (eg the summer months of June, July and 
August)4. We translated these findings into per capita probability in Italy. The per capita probability was as low as 
0.000000167, and we estimated 10 secondary infections which include around 2 symptomatic cases. For Madeira, 
we modeled the probability of an imported case to result in secondary cases to be 0.035 and the expected number 
of secondary cases to be 2205. The difference in the mosquitoes’ species between Italy and Madeira is crucial in 
appreciating the risk difference between the two countries/areas. As Aedes albopictus is a much less competent 
mosquito for dengue transmission than Aedes aegypti, a large number of imported infections to Italy resulted in 
a small number of autochthonous cases, whereas a very small number of imported infections to Madeira resulted 
in a major outbreak.
Our models have several limitations: From an empirical point of view, there is a need for accurate data on 
dengue incidence in the origin countries. We relied on notified dengue cases to WHO, which is probably a sig-
nificant underestimate as recent modeling estimates showed at least 10 to 100 fold higher numbers33. Another 
Figure 4. Expected Number of Passengers Arriving Infected With Dengue in Europe in 2012.
Per capita risk
Expected number of 
autochthonouscases
Italy 1.67E-7 10 ± 1
Madeira 3.35E-2 2205 ± 236
Table 4. Cumulative per capita risk and expected number of autochthonous cases for Italy(Aedesalbopictus) and 
the Madeira Islands (Aedesaegypti). Parameters used for the simulations as in Table S2 (Aedesalbopictus) and S3 
(Aedesaegypti) of the supplementary material.
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limitation is the timing of imports. Here we were restricted to two countries as reference points for fitting monthly 
incidence curves. However, the highest uncertainties in our model were related to mosquito densities in Europe. 
There are no published data on the Aede smosquito abundance in relation to the host population which is a crucial 
parameter for modelling, nor is there sufficient information on biting rates, extrinsic incubation period, mosquito 
longevity under temperate climate conditions except for some pivotal temperature driven data derived from the 
work by Louis Lambrechts’ team at the Institute Pasteur34,35.
We selected the year 2012 for our model parameters (dengue incidence in originating countries and air travel 
volume) in order to validate our model against the actual dengue outbreak that took place in Madeira in that year. 
Validating our model against the reported dengue outbreak in Madeira in 2012, we found that our model fits very 
well with the true number of cases reported: our model results estimated 2205 autochthonous infectious, which is 
well in agreement with the 2180 reported cases in the 2012 outbreak. Therefore, despite its limitations, the model 
proposed here can be very useful in the understanding of the risk of dengue virus importation into still unaffected 
areas, and calculate the probability of secondary cases in those areas where susceptible Aedes mosquitoes exist. 
This paper is hence intended mainly as a novel methodological proposal to estimate the risk of dengue intro-
ductions into Europe and subsequent probability and numbers of secondary (eg locally transmitted) infections.
In conclusion, our estimates highlight that the risk is overall low which probably represents a good approxi-
mation of reality.
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